Analytical Data
-
Gene name
GLT8D2
- Application
-
Alternative Names
GLT8D2；GALA4A；Glycosyltransferase 8 domain-containing Protein 2
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9H1C3
-
Expression Region
25-349aa
-
AA Sequence
KKVHKGTVPKNDADDESETPEELEEEIPVVICAAAGRMGATMAAINSIYSNTDANILFYVVGLRNTLTRIRKWIEHSKLREINFKIVEFNPMVLKGKIRPDSSRPELLQPLNFVRFYLPLLIHQHEKVIYLDDDVIVQGDIQELYDTTLALGHAAAFSDDCDLPSAQDINRLVGLQNTYMGYLDYRKKAIKDLGISPSTCSFNPGVIVANMTEWKHQRITKQLEKWMQKNVEENLYSSSLGGGVATSPMLIVFHGKYSTINPLWHIRHLGWNPDARYSEHFLQEAKLLHWNGRHKPWDFPSVHNDLWESWFVPDPAGIFKLNHHS
-
Molecular Weight
41.2 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
GLT8D2, or glycosyltransferase 8 domain-containing 2, is a member of the glycosyltransferase family that plays a critical role in the modification of glycoproteins and glycolipids, impacting cellular processes such as cell signaling, adhesion, and immune responses. Research has shown that GLT8D2 is involved in various physiological and pathological processes, including its potential link to certain diseases. Understanding the structure and function of GLT8D2 is pivotal in uncovering its biological roles and therapeutic potential. The recombinant expression of GLT8D2 allows researchers to produce the protein in a controlled environment, facilitating biochemical assays and structural studies, which are essential for elucidating its enzymatic activity and substrate specificity. These studies can provide insights into the mechanisms of glycosylation and its implications in disease states, paving the way for novel therapeutic strategies targeting glycosylation pathways. As such, the investigation of GLT8D2 recombinant protein is a significant area of study in molecular biology and biochemistry, offering the potential for advancements in understanding complex cellular interactions and disease mechanisms.
